P. Arvela
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Pharmacology 22
- Pharmacogenetics and Drug Metabolism 19
- Drug-Induced Hepatotoxicity and Protection 9
- Oncology 19
- Drug Transport and Resistance Mechanisms 17
- Co-authors
- Olavi Pelkonen (15 shared papers)Ulrich Klotz (4 shared papers)Niilo T. Kärki (6 shared papers)Bernd Rosenkranz (2 shared papers)Kirsi Vähäkangas (5 shared papers)Arja Rautio (4 shared papers)P. Pienimäki (3 shared papers)Eero A. Sotaniemi (4 shared papers)
In The Last Decade
P. Arvela
47 papers receiving 781 citations
Peers
Comparison fields: 5 of 106
- Pharmacology 265
- Pediatrics, Perinatology and Child Health 182
- Anesthesiology and Pain Medicine 40
- Psychiatry and Mental health 110
- Oncology 177
Countries citing papers authored by P. Arvela
This map shows the geographic impact of P. Arvela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Arvela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Arvela more than expected).
Fields of papers citing papers by P. Arvela
This network shows the impact of papers produced by P. Arvela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Arvela. The network helps show where P. Arvela may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Arvela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 64 | |
| 2 | 1985 | 59 | |
| 3 | 1995 | 58 | |
| 4 | 1972 | 52 | |
| 5 | 1995 | 51 | |
| 6 | 1983 | 51 | |
| 7 | 1985 | 47 | |
| 8 | 1986 | 30 | |
| 9 | 1979 | 29 | |
| 10 | 1979 | 28 | |
| 11 | 1992 | 26 | |
| 12 | 1991 | 22 | |
| 13 | 1971 | 21 | |
| 14 | 1971 | 19 | |
| 15 | 1994 | 19 | |
| 16 | Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in man. | 1997 | 19 |
| 17 | 1971 | 18 | |
| 18 | 1991 | 16 | |
| 19 | 1989 | 14 | |
| 20 | 1983 | 14 |
About P. Arvela
P. Arvela is a scholar working on Pharmacology, Oncology, Pediatrics, Perinatology and Child Health, Molecular Biology and Psychiatry and Mental health, having authored 49 papers that have together received 826 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (19 papers), Drug Transport and Resistance Mechanisms (17 papers), Pharmacological Effects and Toxicity Studies (11 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Metabolism and Genetic Disorders (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Plant and fungal interactions (3 papers) and Migraine and Headache Studies (2 papers). The work is most often cited by research in Pharmacology (265 citations), Pediatrics, Perinatology and Child Health (182 citations), Anesthesiology and Pain Medicine (40 citations), Psychiatry and Mental health (110 citations) and Oncology (177 citations). P. Arvela has collaborated with scholars based in Finland, Germany and Russia. Frequent co-authors include Olavi Pelkonen, Ulrich Klotz, Niilo T. Kärki, Bernd Rosenkranz, Kirsi Vähäkangas, Arja Rautio, P. Pienimäki, Eero A. Sotaniemi, Olavi Pelkonen and Hannu Raunio. Their work appears in journals such as European Journal of Clinical Pharmacology, Cellular and Molecular Life Sciences, Biochemical Pharmacology, British Journal of Clinical Pharmacology and Toxicology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.